$PFE announces its Q4 2024 earnings, reporting EPS of $0.63, beating estimates by $0.17, and revenue of $17.76B, a remarkable 24.66% YoY growth, exceeding expectations.

$AMGN has released its Q4 2024 earnings, featuring an EPS of $5.31, surpassing expectations by $0.23, and revenues of $9.09B, up 10.86% YoY. The company recorded robust product sales growth of 19% for the full year and sustained momentum across key medications like Repatha and EVENITY, with significant unmet patient needs driving future potential.

$AMD has released its Q4 2024 earnings, reporting EPS of $1.09 and revenue of $7.66B, reflecting a 24% y/y growth. The data center and client segments continue to shine, with data center revenue up 69%. However, gaming revenue is down 59%, posing a risk to future growth.

$MPLX reports solid Q4 2024 earnings, with adjusted EBITDA up 9% year-over-year to $1.8 billion, and a 12.5% distribution increase for unitholders. Key highlights include mid-single digit adjusted EBITDA growth continued into 2024, backed by $6.8 billion full-year adjusted EBITDA and strong performance in their Natural Gas and NGL Services.

$DEO has released its fiscal '24 earnings, showing a 0.6% decline in organic net sales, with significant challenges in the Latin America and Caribbean (LAC) region, down 21.1%. In contrast, North America witnessed a slight decline as well, driven by cautious consumer behavior. Despite the challenges, Diageo managed $2.6 billion in free cash flow and a 5% increase in its full-year dividend, reflecting long-term confidence. However, concerns over operational margin persist. Future opportunities lie in leveraging consumer insights and enhancing distribution strategies. For more details, check http://valueverge.com/DEO.

$REGN has released its Q4 2024 earnings, showing notable growth and strong performance across its key products like Dupixent, Libtayo, and EYLEA. Key stats indicate a 10% increase in total revenues to $3.8 billion and an earnings per share rise to $12.07, highlighting robust profitability. However, EYLEA is facing competitive pressure which could impact future growth.

$EPD has released its Q4 2024 earnings report, showcasing stable performance. Key stats reveal an EBITDA of $9.9B and DCF at $7.8B, with a strong distribution growth of 4% year-over-year. Risks include a leverage ratio of 3.1, within the target range of 2.75-3.25.

$RACE is reporting strong earnings for 2024, with revenues hitting approximately €6.7 billion, a 13.4% year-over-year increase, and a net profit of €1.5 billion, reflecting an impressive 22.6% rise in diluted EPS. Key growth areas include a 51% hybrid share and robust personalization demand contributing 20% of car revenues.

$PYPL has released its earnings report, detailing a solid fourth quarter with key metrics showing progress. Revenue grew by 7% for the full year at $32 billion, while total payment volume reached nearly $1.7 trillion. Non-GAAP EPS increased by 21% year-over-year, reflecting enhanced profitability.

Apollo Global Management (APO), 2024 Q4 earnings digest